Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways

Histochemistry and Cell Biology

Volumn 148, Issue 2, 2017, Pages 173-187

  Mascaró, Marilina ^a   Pibuel, Matías A ^a   Lompardía, Silvina L ^a   Díaz, Mariangeles ^a   Zotta, Elsa ^a   Bianconi, Maria I ^b   Lago, Néstor ^a   Otero, Silvina ^b   Jankilevich, Gustavo ^b   Alvarez, Elida ^a   Hajos, Silvia E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DURAND   (Argentina)

Author keywords

Choriocarcinoma; Hyaluronan; Hydatidiform mole; Migration; RHAMM; Signalling pathways

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RHAMM; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; HYALURONAN-MEDIATED MOTILITY RECEPTOR; HYALURONIC ACID BINDING PROTEIN; SCLEROPROTEIN;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHORIOCARCINOMA CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PATHOLOGY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TROPHOBLAST; TROPHOBLASTIC TUMOR; CELL MOTION; CHORIOCARCINOMA; DRUG EFFECTS; MAPK SIGNALING; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

CELL MOVEMENT; CELL PROLIFERATION; CHORIOCARCINOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYALURONAN RECEPTORS; HYALURONIC ACID; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR WEIGHT; PHOSPHATIDYLINOSITOL 3-KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 85016500506     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-017-1559-3     Document Type: Article

References (54)

1. Alaniz L, García MG, Gallo-Rodriguez C, Agusti R, Sterín-Speziale N, Hajos SE, Alvarez E (2006) Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF- B transcription factor. Glycobiology 16:359–367
2. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR (1998) The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 111:1685–1694
3. Averbeck M, Gebhardt CA, Voigt S, Beilharz S, Anderegg U, Termeer CC, Sleeman JP, Simon JC (2006) Differential regulation of hyaluronan metabolism in the epidermal and dermal compartments of human skin by UVB irradiation. J Invest Dermatol 127:687–697
4. Choudhary M, Zhang X, Stojković P, Hyslop L, Anyfantis G, Herbert M, Murdoch AP, Stojković M, Lako M (2007) Putative role of hyaluronan and its related genes, HAS2andRHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization. Stem Cells 25:3045–3057
5. Cole LA (2010) Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 8:102
6. Cordo Russo RI, Alaniz LD, Saccodossi N, Lompardía S, Blanco G, Álvarez É, García MG, Hajos SE (2010) Hyaluronan induces migration of multidrug-resistant lymphoma cell lines in vitro through Tiam1 activation by a PI3K-dependent mechanism. Leuk Res 34:1525–1532
7. Cordo Russo RI, Ernst G, Lompardía S, Blanco G, Álvarez É, Garcia MG, Hajos S (2012) Increased hyaluronan levels and decreased dendritic cell activation are associated with tumor invasion in murine lymphoma cell lines. Immunobiology 217:842–850
8. Dong Y, Arif A, Olsson M, Cali V, Hardman B, Dosanjh M, Lauer M, Midura RJ, Hascall VC, Brown KL, Johnson P (2016) Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-α, interleukin-12 or upregulate costimulatory molecules in dendritic cells or macrophages. Sci Rep 6:36928
9. Ebi H, Costa C, Faber AC, Nishtala M, Kotani H, Juric D, Della Pelle P, Song Y, Yano S, Mino-Kenudson M, Benes CH, Engelman JA (2013) PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc Natl Acad Sci USA 110:21124–21129
10. Ernst G, Jancic C, Auteri S, Rodriguez Moncalvo J, Galíndez F, Grynblat P, Hajos SE (2014) Increased levels of hyaluronic acid in bronchoalveolar lavage from patients with interstitial lung diseases. Relationsh Lung Funct Inflamm Cells Recruit Modern Res Inflamm 03:27–36
11. Gebäck T, Peter Schulz MM, Koumoutsakos P, Detmar M (2009) TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265–274
12. Goshen R, Ariel I, Shuster S, Hochberg A, Vlodavsky I, De Groot N, Ben-Rafael Z, Stern R (1996) Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod 2:685–691
13. Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, Loirand G (2006) Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res 72:339–348
14. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krähn G, Heilmann V, Gschwend J, Bergmann L, Döhner H, Schmitt M (2002) Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol 30:1029–1035
15. Gust KM, Hofer MD, Perner SR, Kim R, Chinnaiyan AM, Varambally S, Moller P, Rinnab L, Rubin MA, Greiner J, Schmitt M, Kuefer R, Ringhoffer M (2009) RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease. Neoplasia 11:956–963
16. Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, Mccarthy JB, Bissell MJ, Koropatnick J, Turley EA (2007) The hyaluronan receptors CD44 and rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 282:16667–16680
17. Hatano H, Shigeishi H, Kudo Y, Higashikawa K, Tobiume K, Takata T, Kamata N (2010) RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44–EGFR. Lab Invest 91:379–391
18. Huang Z, Zhao C, Chen Y, Cowell JA, Wei G, Kultti A, Huang L, Thompson CB, Rosengren S, Frost GI, Shepard HM (2014) Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammation. J Immunol 192:5285–5295
19. Jiang D, Liang J, Noble P (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91:221–264
20. Jiang J, Mohan P, Maxwell CA (2013) The cytoskeletal protein RHAMM and ERK1/2 activity mantain the pluripotency of murine embryonic stem cells. PLoS One 8:e73548
21. Kato HD, Terao Y, Ogawa M, Matsuda T, Arima T, Kato K, Yong Z, Wake N (2002) Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol 21:255–260
22. Kouvidi K, Berdiaki A, Nikitovic D, Katonis P, Afratis N, Hascall VC, Karamanos NK, Tzanakakis GN (2011) Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem 286:38509–38520
23. Lompardía SL, Papademetrio DL, Mascaró M, Álvarez EMDC, Hajos SE (2013) Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy. Glycobiology 23:1463–1476
24. Lompardía SL, Díaz M, Papademetrio DL, Mascaró M, Pibuel M, Álvarez E, Hajos SE (2016) Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib. Glycobiology 26:343–352
25. Lugli A, Iezzi G, Hostettler I, Muraro MG, Mele V, Tornillo L, Carafa V, Spagnoli G, Terracciano L, Zlobec I (2010) Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 103:382–390
26. Mangili G, Lorusso D, Brown J, Pfisterer J, Massuger L, Vaughan M, Ngan H, Golfier F, Sekharan P, Cortés Charry R, Poveda A, Kim J, Xiang Y, Berkowtiz R, Seckl M (2014) Trophoblastic disease review for diagnosis and management. Int J Gynecol Cancer 24:109–116
27. Mao T-L, Kurman RJ, Huang C-C, Lin M-C, Shih I-M (2007) Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 31:1726–1732
28. Maxwell CA, Mccarthy J, Turley E (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci 121:925–932
29. Monslow J, Govindaraju P, Puré E (2015) Hyaluronan—a functional and structural sweet spot in the tissue microenvironment frontiers. Immunology 6:231
30. Naor D (2016) Editorial: interaction between hyaluronic acid and its receptors (CD44 RHAMM) regulates the activity of inflammation cancer. Front Immunol 7:39
31. Niba ETE, Nagaya H, Kanno T, Tsuchiya A, Gotoh A, Tabata C, Kuribayashi K, Nakano T, Nishizaki T (2013) Crosstalk between PI3 Kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor. Cell Physiol Biochem 31:905–913
32. Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, Morley R, Down T, Beck S, Craig JM, Saffery R (2008) Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 14:547–554
33. Park D, Kim Y, Kim H, Kim K, Lee Y-S, Choe J, Hahn J-H, Lee H, Jeon J, Choi C, Kim Y-M, Jeoung D (2012) Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ. Mol Cells 33:563–574
34. Red-Horse K (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114:744–754
35. Reynolds E, Dubeshter B, Katzman P, Larson K, Katzel S, Glantz C (2007) Expression of CD44, E-cadherin, and antimetastatic protein nm23-H1 in complete hydatidiform moles. Gynecol Oncol 104:451–454
36. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, Delisser HM (2001) Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276:36770–36778
37. Sebire N (2010) Histopathological diagnosis of hydatiform mole: contemporary features and clinical implications fetal and pediatric. Pathology 29:1–16
38. Sebire NJ, Lindsay I (2010) Current issues in the histopathology of gestational trophoblastic tumors fetal and pediatric. Pathology 29:30–44
39. Shih I-M (2007) Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets The. Lancet Oncol 8:642–650
40. Singer G, Kurman RJ, Mcmaster M, Shih I (2002) HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 7:914–920
41. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM (2011) Hyaluronan in human malignancies. Exp Cell Res 317:383–391
42. Stern R, Jedrzejas M (2006) Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 106:818–839
43. Takahashi H, Takizawa T, Matsubara S, Ohkuchi A, Kuwata T, Usui R, Matsumoto H, Sato Y, Fujiwara H, Okamoto A, Suzuki M, Takizawa T (2014) Extravillous trophoblast cell invasion is promoted by the CD44-hyaluronic acid interaction. Placenta 35(3):163–170
44. Toole BP (2009) Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res 15:7462–7468
45. Turley EA, Naor D (2012) RHAMM and CD44 peptides-analytic tools and potential drugs. Front Biosci 1:1775–1794
46. Turley E, Noble P, Bourguignon L (2001) Signaling properties of hyaluronan receptors. J Biol Chem 277:4589–4592
47. Turley EA, Wood DK, Mccarthy JB (2016) Carcinoma cell hyaluronan as a “portable” cancerized prometastatic microenvironment. Cancer Res 76:2507–2512
48. Twarock S, Tammi MI, Savani RC, Fischer JW (2010) Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J Biol Chem 285:23276–23284
49. Vargas A, Moreau J, Landry S, Lebellego F, Toufaily C, Rassart E, Lafond J, Barbeau B (2009) Syncytin-2 plays an important role in the fusion of human trophoblast cells. J Mol Biol 392:301–318
50. Wang C, Thor A, Moore DN, Zhao Y, Kerschmann R, Stern R, Watson P, Turley E (1998) The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 4:567–576
51. Weigel PH, Deangelis PL (2007) Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282:36777–36781
52. Zhang S, Chang M, Zylka D, Turley S, Harrison R, Turley E (1998) The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem 273:11342–11348
53. Zhu R, Huang YH, Tao Y, Wang SC, Sun C, Piao HL, Wang XQ, Du MR, Li DJ (2013) Hyaluronan up-regulates growth and invasion of trophoblasts in an autocrine manner via PI3K/AKT and MAPK/ERK1/2 pathways in early human pregnancy. Placenta 34:784–791
54. Zoller M (2015) CD44, hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells frontiers. Immunology 6:235